| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| ATP-Binding Cassette Transporters | 16 | 2013 | 567 | 2.280 |
Why?
|
| Pyrans | 5 | 2023 | 49 | 1.850 |
Why?
|
| Metformin | 4 | 2023 | 909 | 1.830 |
Why?
|
| Cholesterol | 16 | 2011 | 2914 | 1.060 |
Why?
|
| Receptors, Immunologic | 12 | 2005 | 1418 | 1.030 |
Why?
|
| Arteriosclerosis | 10 | 2005 | 1055 | 0.980 |
Why?
|
| Apolipoprotein A-I | 9 | 2008 | 305 | 0.910 |
Why?
|
| Deglutition Disorders | 2 | 2019 | 640 | 0.860 |
Why?
|
| Lipoproteins, LDL | 13 | 2006 | 644 | 0.820 |
Why?
|
| Macrophages | 17 | 2008 | 5799 | 0.780 |
Why?
|
| Diabetes Mellitus, Type 2 | 7 | 2023 | 12252 | 0.750 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 6 | 2003 | 859 | 0.730 |
Why?
|
| Aldosterone | 2 | 2022 | 881 | 0.720 |
Why?
|
| Receptors, Lipoprotein | 6 | 2002 | 88 | 0.670 |
Why?
|
| Hypertension | 4 | 2023 | 8616 | 0.620 |
Why?
|
| Receptors, Scavenger | 13 | 2006 | 123 | 0.620 |
Why?
|
| Urination Disorders | 1 | 2019 | 236 | 0.610 |
Why?
|
| Renal Insufficiency | 1 | 2024 | 812 | 0.590 |
Why?
|
| Hypoglycemic Agents | 6 | 2023 | 3109 | 0.550 |
Why?
|
| Scavenger Receptors, Class A | 7 | 2008 | 52 | 0.540 |
Why?
|
| Myositis | 1 | 2019 | 269 | 0.530 |
Why?
|
| Antihypertensive Agents | 2 | 2023 | 2029 | 0.520 |
Why?
|
| Muscular Diseases | 1 | 2019 | 553 | 0.490 |
Why?
|
| Foam Cells | 5 | 2008 | 68 | 0.490 |
Why?
|
| Cholesterol, HDL | 6 | 2007 | 1820 | 0.470 |
Why?
|
| Glucosylceramides | 1 | 2013 | 27 | 0.450 |
Why?
|
| Hyperlipidemias | 3 | 2008 | 772 | 0.440 |
Why?
|
| Double-Blind Method | 8 | 2023 | 12465 | 0.430 |
Why?
|
| Glucosylceramidase | 1 | 2013 | 125 | 0.420 |
Why?
|
| Tangier Disease | 5 | 2011 | 11 | 0.420 |
Why?
|
| Lipid Metabolism | 4 | 2006 | 1904 | 0.390 |
Why?
|
| Renal Insufficiency, Chronic | 2 | 2024 | 2298 | 0.390 |
Why?
|
| Ceramides | 2 | 2013 | 203 | 0.380 |
Why?
|
| Lipopolysaccharides | 7 | 2005 | 2219 | 0.380 |
Why?
|
| Macrophages, Peritoneal | 6 | 2005 | 244 | 0.380 |
Why?
|
| Epidermis | 1 | 2013 | 539 | 0.360 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 3 | 2019 | 3251 | 0.330 |
Why?
|
| Kidney Diseases | 1 | 2019 | 2100 | 0.310 |
Why?
|
| Area Under Curve | 2 | 2023 | 1643 | 0.310 |
Why?
|
| Mice, Knockout | 19 | 2013 | 14488 | 0.300 |
Why?
|
| Microarray Analysis | 3 | 2006 | 753 | 0.290 |
Why?
|
| Esters | 1 | 2008 | 212 | 0.290 |
Why?
|
| Muscle, Skeletal | 2 | 2019 | 4978 | 0.280 |
Why?
|
| Phosphatidylglycerols | 1 | 2006 | 35 | 0.280 |
Why?
|
| Autoimmune Diseases | 1 | 2019 | 2257 | 0.280 |
Why?
|
| Macrophage Activation | 3 | 2004 | 557 | 0.270 |
Why?
|
| Pulmonary Surfactants | 1 | 2006 | 169 | 0.260 |
Why?
|
| Dystrophin-Associated Proteins | 1 | 2005 | 60 | 0.250 |
Why?
|
| Cholesterol Esters | 1 | 2005 | 72 | 0.250 |
Why?
|
| Apolipoproteins E | 5 | 2008 | 1461 | 0.240 |
Why?
|
| Antigens, Differentiation | 2 | 2004 | 921 | 0.230 |
Why?
|
| Atherosclerosis | 4 | 2008 | 3433 | 0.230 |
Why?
|
| Mice | 37 | 2021 | 82029 | 0.220 |
Why?
|
| Lipids | 4 | 2013 | 3343 | 0.220 |
Why?
|
| Receptors, Cell Surface | 6 | 2005 | 2819 | 0.220 |
Why?
|
| Receptors, LDL | 4 | 1998 | 493 | 0.220 |
Why?
|
| Signal Transduction | 10 | 2005 | 23645 | 0.210 |
Why?
|
| Phosphatidylcholines | 1 | 2004 | 406 | 0.210 |
Why?
|
| Animals | 50 | 2021 | 169246 | 0.200 |
Why?
|
| Immunity, Innate | 2 | 2005 | 3080 | 0.200 |
Why?
|
| Blood Glucose | 3 | 2023 | 6430 | 0.200 |
Why?
|
| Bile Acids and Salts | 2 | 2002 | 398 | 0.200 |
Why?
|
| Membrane Glycoproteins | 5 | 2005 | 3711 | 0.190 |
Why?
|
| Apolipoproteins | 1 | 2003 | 328 | 0.190 |
Why?
|
| Membrane Proteins | 6 | 2002 | 7876 | 0.180 |
Why?
|
| Blood Pressure | 3 | 2022 | 8543 | 0.180 |
Why?
|
| Humans | 56 | 2024 | 768166 | 0.170 |
Why?
|
| Scavenger Receptors, Class B | 6 | 2002 | 85 | 0.170 |
Why?
|
| Mice, Inbred C57BL | 18 | 2021 | 22379 | 0.170 |
Why?
|
| Myoglobinuria | 1 | 2019 | 22 | 0.170 |
Why?
|
| Nitric Oxide Synthase | 1 | 2022 | 911 | 0.170 |
Why?
|
| Matrix Metalloproteinase 3 | 1 | 2000 | 139 | 0.160 |
Why?
|
| Protein Binding | 6 | 2008 | 9343 | 0.160 |
Why?
|
| Heterozygote | 3 | 2008 | 2798 | 0.160 |
Why?
|
| Statistics, Nonparametric | 1 | 2005 | 2862 | 0.160 |
Why?
|
| Lipoproteins | 3 | 2000 | 880 | 0.160 |
Why?
|
| Drug Interactions | 1 | 2023 | 1419 | 0.150 |
Why?
|
| Rhabdomyolysis | 1 | 2019 | 150 | 0.150 |
Why?
|
| Respiratory Insufficiency | 1 | 2006 | 1240 | 0.150 |
Why?
|
| Inflammation | 5 | 2008 | 10873 | 0.150 |
Why?
|
| Gene Expression Regulation | 5 | 2008 | 11928 | 0.140 |
Why?
|
| Carotid Artery, Internal | 1 | 2019 | 440 | 0.130 |
Why?
|
| Hypercholesterolemia | 5 | 2007 | 1145 | 0.130 |
Why?
|
| Cross-Over Studies | 1 | 2023 | 2107 | 0.130 |
Why?
|
| Transcription Factors | 5 | 2004 | 12168 | 0.130 |
Why?
|
| Muscle, Smooth, Vascular | 4 | 2005 | 1493 | 0.130 |
Why?
|
| Leukocytes, Mononuclear | 2 | 2002 | 1854 | 0.130 |
Why?
|
| Muscle Weakness | 1 | 2019 | 412 | 0.130 |
Why?
|
| Cardiovascular System | 1 | 2023 | 841 | 0.130 |
Why?
|
| Cell Line | 11 | 2005 | 15597 | 0.130 |
Why?
|
| Transfection | 5 | 2005 | 5755 | 0.130 |
Why?
|
| Mutation | 9 | 2011 | 30238 | 0.130 |
Why?
|
| Glomerular Filtration Rate | 1 | 2024 | 2227 | 0.120 |
Why?
|
| Biotechnology | 1 | 2017 | 283 | 0.120 |
Why?
|
| Biological Transport, Active | 2 | 2005 | 323 | 0.120 |
Why?
|
| Data Interpretation, Statistical | 1 | 2005 | 2709 | 0.120 |
Why?
|
| Ligands | 4 | 2003 | 3284 | 0.120 |
Why?
|
| Hydrocortisone | 1 | 2022 | 1841 | 0.120 |
Why?
|
| Cerebral Infarction | 1 | 2019 | 969 | 0.120 |
Why?
|
| Drug Therapy, Combination | 2 | 2023 | 6316 | 0.110 |
Why?
|
| Chromatography, Thin Layer | 1 | 2013 | 212 | 0.110 |
Why?
|
| Emigration and Immigration | 1 | 2017 | 406 | 0.110 |
Why?
|
| Diet, Atherogenic | 3 | 2005 | 92 | 0.110 |
Why?
|
| Promoter Regions, Genetic | 3 | 2000 | 5797 | 0.110 |
Why?
|
| Hyperkalemia | 1 | 2015 | 234 | 0.100 |
Why?
|
| Gene Deletion | 1 | 2000 | 2675 | 0.100 |
Why?
|
| Public Policy | 1 | 2017 | 552 | 0.100 |
Why?
|
| Adipose Tissue | 1 | 2004 | 3329 | 0.100 |
Why?
|
| Metabolism, Inborn Errors | 1 | 2015 | 292 | 0.100 |
Why?
|
| Lasers, Solid-State | 2 | 2012 | 183 | 0.100 |
Why?
|
| Magnetic Resonance Angiography | 1 | 2019 | 1429 | 0.100 |
Why?
|
| Glycoproteins | 1 | 2000 | 2202 | 0.100 |
Why?
|
| Diffusion of Innovation | 1 | 2017 | 724 | 0.100 |
Why?
|
| Receptors, Leukotriene B4 | 2 | 2005 | 93 | 0.100 |
Why?
|
| Escherichia coli | 2 | 2005 | 4214 | 0.100 |
Why?
|
| Fibroblasts | 4 | 2002 | 4176 | 0.100 |
Why?
|
| Protein Structure, Tertiary | 3 | 2004 | 3772 | 0.100 |
Why?
|
| Hyperlipoproteinemia Type II | 2 | 2015 | 407 | 0.100 |
Why?
|
| Amyloid beta-Peptides | 2 | 2003 | 3914 | 0.100 |
Why?
|
| Biological Transport | 4 | 2011 | 2085 | 0.100 |
Why?
|
| Enzyme Inhibitors | 1 | 2022 | 3728 | 0.100 |
Why?
|
| Angiogenesis Inhibitors | 2 | 2012 | 2056 | 0.100 |
Why?
|
| Kidney | 2 | 2024 | 7064 | 0.100 |
Why?
|
| Mice, Transgenic | 3 | 2002 | 9561 | 0.100 |
Why?
|
| Technology Transfer | 1 | 2011 | 41 | 0.090 |
Why?
|
| Immunohistochemistry | 6 | 2013 | 11095 | 0.090 |
Why?
|
| Organ Culture Techniques | 1 | 2013 | 794 | 0.090 |
Why?
|
| Antibodies, Neutralizing | 1 | 2021 | 2011 | 0.090 |
Why?
|
| Coronary Disease | 1 | 2006 | 5919 | 0.090 |
Why?
|
| Aged | 12 | 2019 | 171504 | 0.090 |
Why?
|
| Amino Acid Sequence | 8 | 2004 | 13421 | 0.090 |
Why?
|
| Program Development | 1 | 2017 | 1300 | 0.090 |
Why?
|
| Potassium | 1 | 2015 | 1315 | 0.090 |
Why?
|
| Therapeutics | 1 | 2011 | 113 | 0.090 |
Why?
|
| Papilloma | 1 | 2011 | 143 | 0.090 |
Why?
|
| Female | 25 | 2021 | 397192 | 0.090 |
Why?
|
| Aryl Hydrocarbon Hydroxylases | 1 | 2011 | 246 | 0.090 |
Why?
|
| Mixed Function Oxygenases | 1 | 2011 | 265 | 0.090 |
Why?
|
| Immunoblotting | 1 | 2013 | 1647 | 0.090 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2022 | 10760 | 0.090 |
Why?
|
| Protein Sorting Signals | 2 | 1989 | 274 | 0.090 |
Why?
|
| Cell Differentiation | 6 | 2002 | 11669 | 0.090 |
Why?
|
| Molecular Sequence Data | 8 | 2004 | 17622 | 0.090 |
Why?
|
| Models, Statistical | 1 | 2005 | 5107 | 0.090 |
Why?
|
| Gene Expression Profiling | 4 | 2008 | 9538 | 0.090 |
Why?
|
| Dendritic Cells | 1 | 2001 | 2747 | 0.080 |
Why?
|
| Antibodies, Viral | 1 | 2021 | 3216 | 0.080 |
Why?
|
| Models, Genetic | 3 | 2011 | 3447 | 0.080 |
Why?
|
| Cell Adhesion Molecules | 2 | 1993 | 1613 | 0.080 |
Why?
|
| Adenoviridae | 3 | 2003 | 1092 | 0.080 |
Why?
|
| DNA | 4 | 2002 | 7214 | 0.080 |
Why?
|
| Antibody Specificity | 2 | 2001 | 1065 | 0.080 |
Why?
|
| NF-kappa B | 4 | 2005 | 2493 | 0.080 |
Why?
|
| Industry | 1 | 2011 | 362 | 0.080 |
Why?
|
| Macrophage-1 Antigen | 2 | 2000 | 286 | 0.080 |
Why?
|
| Recombinant Fusion Proteins | 3 | 2004 | 3740 | 0.080 |
Why?
|
| Tyrosine | 2 | 2003 | 1427 | 0.080 |
Why?
|
| Toll-Like Receptors | 4 | 2005 | 582 | 0.080 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2015 | 1515 | 0.080 |
Why?
|
| Laryngeal Diseases | 1 | 2011 | 248 | 0.080 |
Why?
|
| Serine C-Palmitoyltransferase | 1 | 2008 | 42 | 0.080 |
Why?
|
| Toll-Like Receptor 4 | 4 | 2005 | 588 | 0.080 |
Why?
|
| Recombinant Proteins | 3 | 2005 | 6514 | 0.080 |
Why?
|
| Diabetic Nephropathies | 1 | 2015 | 973 | 0.080 |
Why?
|
| Polymers | 1 | 2015 | 1630 | 0.070 |
Why?
|
| RNA | 2 | 2008 | 2720 | 0.070 |
Why?
|
| Cells, Cultured | 9 | 2004 | 19015 | 0.070 |
Why?
|
| Parathyroid Hormone | 3 | 1992 | 1804 | 0.070 |
Why?
|
| Aorta | 4 | 2008 | 2045 | 0.070 |
Why?
|
| Linoleic Acid | 1 | 2008 | 158 | 0.070 |
Why?
|
| Skin | 2 | 2013 | 4503 | 0.070 |
Why?
|
| Phagocytosis | 3 | 2002 | 1530 | 0.070 |
Why?
|
| Treatment Outcome | 5 | 2023 | 65371 | 0.070 |
Why?
|
| Dyslipidemias | 1 | 2015 | 873 | 0.070 |
Why?
|
| Luminescent Proteins | 2 | 2001 | 838 | 0.070 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2006 | 3800 | 0.070 |
Why?
|
| Vocal Cords | 1 | 2011 | 520 | 0.070 |
Why?
|
| Adult | 11 | 2023 | 223646 | 0.070 |
Why?
|
| Lipoproteins, HDL | 3 | 2000 | 682 | 0.070 |
Why?
|
| HEK293 Cells | 2 | 2013 | 4283 | 0.070 |
Why?
|
| Protein Precursors | 2 | 1989 | 1134 | 0.070 |
Why?
|
| Tumor Necrosis Factor-alpha | 7 | 2003 | 4352 | 0.070 |
Why?
|
| Particle Size | 3 | 2000 | 1649 | 0.070 |
Why?
|
| Permeability | 1 | 2008 | 725 | 0.070 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2013 | 4580 | 0.070 |
Why?
|
| Research Personnel | 1 | 2011 | 589 | 0.070 |
Why?
|
| Reactive Oxygen Species | 3 | 2003 | 2149 | 0.070 |
Why?
|
| Gene Expression | 4 | 2005 | 7598 | 0.060 |
Why?
|
| RNA, Messenger | 5 | 2008 | 12800 | 0.060 |
Why?
|
| Drug Design | 1 | 2011 | 1046 | 0.060 |
Why?
|
| Luciferases | 2 | 2000 | 713 | 0.060 |
Why?
|
| Copper | 2 | 2002 | 368 | 0.060 |
Why?
|
| Universities | 1 | 2011 | 1005 | 0.060 |
Why?
|
| Base Sequence | 6 | 2001 | 12421 | 0.060 |
Why?
|
| Mice, Inbred BALB C | 4 | 2021 | 6231 | 0.060 |
Why?
|
| Male | 22 | 2021 | 364719 | 0.060 |
Why?
|
| Amyloid beta-Protein Precursor | 1 | 2011 | 1117 | 0.060 |
Why?
|
| Microscopy, Electron | 1 | 2008 | 2560 | 0.060 |
Why?
|
| Cell Line, Transformed | 2 | 2003 | 866 | 0.060 |
Why?
|
| Sinus of Valsalva | 1 | 2005 | 60 | 0.060 |
Why?
|
| Liver | 1 | 2001 | 7577 | 0.060 |
Why?
|
| Mitogen-Activated Protein Kinase 9 | 1 | 2004 | 29 | 0.060 |
Why?
|
| Antigens, Differentiation, Myelomonocytic | 2 | 1998 | 283 | 0.060 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2006 | 687 | 0.060 |
Why?
|
| Escherichia coli K12 | 1 | 2004 | 35 | 0.060 |
Why?
|
| Fenofibrate | 1 | 2005 | 87 | 0.060 |
Why?
|
| Respiratory Tract Infections | 1 | 2012 | 1014 | 0.060 |
Why?
|
| Middle Aged | 12 | 2019 | 223492 | 0.060 |
Why?
|
| Carrier Proteins | 4 | 2005 | 4937 | 0.060 |
Why?
|
| DNA Probes | 2 | 2006 | 542 | 0.060 |
Why?
|
| Green Fluorescent Proteins | 2 | 2001 | 2065 | 0.060 |
Why?
|
| Leukotriene B4 | 1 | 2005 | 281 | 0.060 |
Why?
|
| Receptors, Purinergic P2 | 1 | 2005 | 152 | 0.060 |
Why?
|
| Cell Membrane | 3 | 2003 | 3655 | 0.060 |
Why?
|
| Cardiovascular Diseases | 2 | 2023 | 15662 | 0.060 |
Why?
|
| Myocytes, Smooth Muscle | 2 | 2005 | 702 | 0.060 |
Why?
|
| Sequence Deletion | 2 | 2005 | 1497 | 0.060 |
Why?
|
| Diagnosis, Differential | 1 | 2019 | 13014 | 0.060 |
Why?
|
| Crosses, Genetic | 2 | 2002 | 752 | 0.060 |
Why?
|
| Homozygote | 2 | 2006 | 1779 | 0.060 |
Why?
|
| Microglia | 2 | 2003 | 1376 | 0.060 |
Why?
|
| Phosphorylation | 3 | 2004 | 8317 | 0.060 |
Why?
|
| Genotype | 3 | 2011 | 13045 | 0.060 |
Why?
|
| Temperature | 2 | 2002 | 2234 | 0.050 |
Why?
|
| Azetidines | 1 | 2005 | 152 | 0.050 |
Why?
|
| Interferon Regulatory Factor-3 | 1 | 2004 | 146 | 0.050 |
Why?
|
| Teichoic Acids | 1 | 2003 | 70 | 0.050 |
Why?
|
| Cytokines | 5 | 2005 | 7453 | 0.050 |
Why?
|
| Warfarin | 1 | 2011 | 1493 | 0.050 |
Why?
|
| 3T3 Cells | 1 | 2004 | 1084 | 0.050 |
Why?
|
| Myeloid Differentiation Factor 88 | 2 | 2004 | 582 | 0.050 |
Why?
|
| Amino Acid Motifs | 1 | 2005 | 930 | 0.050 |
Why?
|
| Genes, Reporter | 2 | 1998 | 1524 | 0.050 |
Why?
|
| Peritonitis | 2 | 2002 | 368 | 0.050 |
Why?
|
| Phospholipids | 1 | 2006 | 787 | 0.050 |
Why?
|
| Proto-Oncogene Proteins c-fyn | 1 | 2002 | 114 | 0.050 |
Why?
|
| Myocardial Infarction | 1 | 2023 | 11519 | 0.050 |
Why?
|
| Salmonella Infections, Animal | 1 | 2002 | 60 | 0.050 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2015 | 3671 | 0.050 |
Why?
|
| Transduction, Genetic | 2 | 2003 | 899 | 0.050 |
Why?
|
| Drosophila Proteins | 2 | 2002 | 1712 | 0.050 |
Why?
|
| Cyclic AMP | 2 | 1999 | 1470 | 0.050 |
Why?
|
| Disease Models, Animal | 2 | 2008 | 18349 | 0.050 |
Why?
|
| Peptides | 2 | 2004 | 4354 | 0.050 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 1 | 2002 | 354 | 0.050 |
Why?
|
| Models, Chemical | 1 | 2004 | 611 | 0.050 |
Why?
|
| Precipitin Tests | 1 | 2002 | 816 | 0.050 |
Why?
|
| Sequence Alignment | 2 | 2004 | 2179 | 0.050 |
Why?
|
| Stroke | 1 | 2023 | 9755 | 0.050 |
Why?
|
| Acute-Phase Proteins | 1 | 2002 | 252 | 0.050 |
Why?
|
| CCAAT-Enhancer-Binding Protein-alpha | 1 | 2002 | 130 | 0.050 |
Why?
|
| Macromolecular Substances | 1 | 2003 | 1435 | 0.050 |
Why?
|
| Animals, Newborn | 1 | 2006 | 2678 | 0.050 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2002 | 474 | 0.050 |
Why?
|
| Streptococcus agalactiae | 1 | 2002 | 337 | 0.050 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2002 | 478 | 0.040 |
Why?
|
| Protein Biosynthesis | 3 | 2001 | 2094 | 0.040 |
Why?
|
| Academic Medical Centers | 1 | 2011 | 2784 | 0.040 |
Why?
|
| Hypolipidemic Agents | 1 | 2005 | 609 | 0.040 |
Why?
|
| Papillomavirus Infections | 1 | 2012 | 1640 | 0.040 |
Why?
|
| Endothelium, Vascular | 1 | 1992 | 4427 | 0.040 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 1 | 2000 | 283 | 0.040 |
Why?
|
| Lipid Bilayers | 1 | 2002 | 379 | 0.040 |
Why?
|
| Oxandrolone | 1 | 1980 | 24 | 0.040 |
Why?
|
| RNA, Small Interfering | 2 | 2008 | 3428 | 0.040 |
Why?
|
| Mutagenesis | 1 | 2004 | 1228 | 0.040 |
Why?
|
| src-Family Kinases | 1 | 2002 | 539 | 0.040 |
Why?
|
| Intestinal Absorption | 1 | 2001 | 400 | 0.040 |
Why?
|
| Respiratory Syncytial Viruses | 1 | 2000 | 168 | 0.040 |
Why?
|
| Heart Failure | 1 | 2023 | 11879 | 0.040 |
Why?
|
| Bacterial Adhesion | 1 | 2000 | 305 | 0.040 |
Why?
|
| Receptors, Lipoxin | 1 | 1999 | 83 | 0.040 |
Why?
|
| Blotting, Western | 2 | 2007 | 5027 | 0.040 |
Why?
|
| Macaca fascicularis | 1 | 2021 | 912 | 0.040 |
Why?
|
| Cross-Linking Reagents | 1 | 2002 | 693 | 0.040 |
Why?
|
| Multiprotein Complexes | 1 | 2005 | 1110 | 0.040 |
Why?
|
| Gene Silencing | 1 | 2005 | 1505 | 0.040 |
Why?
|
| Apolipoproteins B | 1 | 2000 | 386 | 0.040 |
Why?
|
| Genomics | 1 | 2015 | 5926 | 0.040 |
Why?
|
| Receptors, Formyl Peptide | 1 | 1999 | 146 | 0.040 |
Why?
|
| Hydroxyeicosatetraenoic Acids | 1 | 1999 | 225 | 0.040 |
Why?
|
| Collagen | 2 | 1998 | 2643 | 0.040 |
Why?
|
| Genetic Markers | 1 | 2004 | 2603 | 0.040 |
Why?
|
| Chromosome Mapping | 1 | 2006 | 4620 | 0.040 |
Why?
|
| Transgenes | 1 | 2021 | 1016 | 0.040 |
Why?
|
| Mutagenesis, Insertional | 1 | 2000 | 661 | 0.040 |
Why?
|
| Bacterial Outer Membrane Proteins | 1 | 2000 | 404 | 0.040 |
Why?
|
| DNA, Complementary | 1 | 2001 | 1989 | 0.040 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2002 | 1245 | 0.040 |
Why?
|
| CHO Cells | 3 | 2011 | 1379 | 0.030 |
Why?
|
| Polysaccharides | 1 | 2003 | 1024 | 0.030 |
Why?
|
| Binding Sites | 1 | 2005 | 6020 | 0.030 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2004 | 2909 | 0.030 |
Why?
|
| Metalloendopeptidases | 1 | 1998 | 386 | 0.030 |
Why?
|
| Glucose | 1 | 2008 | 4352 | 0.030 |
Why?
|
| Lipoxins | 1 | 1999 | 419 | 0.030 |
Why?
|
| COS Cells | 1 | 1998 | 1135 | 0.030 |
Why?
|
| Cell Movement | 3 | 2005 | 5210 | 0.030 |
Why?
|
| Dependovirus | 1 | 2021 | 720 | 0.030 |
Why?
|
| Cricetinae | 3 | 2011 | 2423 | 0.030 |
Why?
|
| National Cancer Institute (U.S.) | 1 | 2017 | 300 | 0.030 |
Why?
|
| Models, Biological | 2 | 2002 | 9495 | 0.030 |
Why?
|
| Genetic Vectors | 2 | 2000 | 3402 | 0.030 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2019 | 20760 | 0.030 |
Why?
|
| Pedigree | 2 | 2000 | 4539 | 0.030 |
Why?
|
| Antigens, CD | 2 | 1998 | 4035 | 0.030 |
Why?
|
| Biomedical Research | 1 | 2011 | 3463 | 0.030 |
Why?
|
| Gene Rearrangement | 1 | 2000 | 1146 | 0.030 |
Why?
|
| Models, Molecular | 1 | 2005 | 5403 | 0.030 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2002 | 3814 | 0.030 |
Why?
|
| Glycosylation | 1 | 1998 | 1100 | 0.030 |
Why?
|
| Biotransformation | 1 | 2015 | 166 | 0.030 |
Why?
|
| Herpesvirus 4, Human | 1 | 2000 | 1082 | 0.030 |
Why?
|
| Population Dynamics | 1 | 2017 | 314 | 0.030 |
Why?
|
| Adipocytes | 1 | 2002 | 1197 | 0.030 |
Why?
|
| Least-Squares Analysis | 1 | 2015 | 367 | 0.030 |
Why?
|
| Proteins | 2 | 2004 | 6009 | 0.030 |
Why?
|
| Human Genome Project | 1 | 2015 | 202 | 0.030 |
Why?
|
| Macaca mulatta | 1 | 2021 | 2363 | 0.030 |
Why?
|
| Tumor Cells, Cultured | 2 | 2000 | 6124 | 0.030 |
Why?
|
| Immunologic Memory | 1 | 2021 | 1377 | 0.030 |
Why?
|
| Weight Gain | 1 | 2004 | 2359 | 0.030 |
Why?
|
| Haplotypes | 1 | 2000 | 2722 | 0.030 |
Why?
|
| Embryo, Mammalian | 1 | 2000 | 1676 | 0.030 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2000 | 1367 | 0.030 |
Why?
|
| Time Factors | 4 | 2002 | 40218 | 0.030 |
Why?
|
| Dehydroascorbic Acid | 1 | 1993 | 3 | 0.030 |
Why?
|
| Thiazoles | 1 | 2001 | 1542 | 0.030 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 1995 | 781 | 0.030 |
Why?
|
| Mutation, Missense | 1 | 2002 | 2592 | 0.030 |
Why?
|
| Cell Proliferation | 1 | 2008 | 10474 | 0.030 |
Why?
|
| Lung | 3 | 2006 | 10099 | 0.030 |
Why?
|
| Reperfusion Injury | 1 | 1999 | 1039 | 0.030 |
Why?
|
| Reference Values | 1 | 2000 | 4938 | 0.030 |
Why?
|
| Interleukin-6 | 2 | 2002 | 3228 | 0.030 |
Why?
|
| Anticholesteremic Agents | 1 | 1980 | 972 | 0.030 |
Why?
|
| Feeding Behavior | 1 | 2004 | 3205 | 0.030 |
Why?
|
| Neutrophils | 2 | 2002 | 3786 | 0.030 |
Why?
|
| Cloning, Molecular | 2 | 1995 | 4168 | 0.030 |
Why?
|
| Inositol Phosphates | 1 | 1992 | 175 | 0.020 |
Why?
|
| Viral Load | 1 | 2021 | 3396 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2002 | 5902 | 0.020 |
Why?
|
| Lipid Peroxidation | 1 | 1993 | 276 | 0.020 |
Why?
|
| Conserved Sequence | 1 | 1995 | 1162 | 0.020 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 1992 | 826 | 0.020 |
Why?
|
| Alleles | 1 | 2002 | 6894 | 0.020 |
Why?
|
| Protein Processing, Post-Translational | 2 | 2011 | 1966 | 0.020 |
Why?
|
| Oxygen | 1 | 2002 | 4270 | 0.020 |
Why?
|
| Mice, Inbred CBA | 2 | 2002 | 439 | 0.020 |
Why?
|
| Renin-Angiotensin System | 1 | 2015 | 737 | 0.020 |
Why?
|
| Cytoplasm | 1 | 1995 | 1505 | 0.020 |
Why?
|
| Protein Conformation | 1 | 1998 | 3956 | 0.020 |
Why?
|
| Monocytes | 1 | 2000 | 2605 | 0.020 |
Why?
|
| American Heart Association | 1 | 2015 | 1050 | 0.020 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2002 | 4528 | 0.020 |
Why?
|
| DNA-Binding Proteins | 2 | 2004 | 9615 | 0.020 |
Why?
|
| Phonation | 1 | 2011 | 221 | 0.020 |
Why?
|
| Rabbits | 2 | 1995 | 4772 | 0.020 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2015 | 1338 | 0.020 |
Why?
|
| International Normalized Ratio | 1 | 2011 | 382 | 0.020 |
Why?
|
| Nomograms | 1 | 2011 | 236 | 0.020 |
Why?
|
| Membrane Lipids | 1 | 2011 | 252 | 0.020 |
Why?
|
| Membrane Microdomains | 1 | 2011 | 205 | 0.020 |
Why?
|
| Ascorbic Acid | 1 | 1993 | 658 | 0.020 |
Why?
|
| Antigens, Surface | 1 | 1993 | 1617 | 0.020 |
Why?
|
| Vaccination | 1 | 2021 | 3437 | 0.020 |
Why?
|
| Cricetulus | 1 | 2011 | 812 | 0.020 |
Why?
|
| Clinical Trials as Topic | 1 | 2005 | 8054 | 0.020 |
Why?
|
| Cardiovascular Agents | 1 | 2015 | 849 | 0.020 |
Why?
|
| Injections | 1 | 2011 | 840 | 0.020 |
Why?
|
| T-Lymphocytes | 2 | 2021 | 10266 | 0.020 |
Why?
|
| Aspirin | 1 | 1999 | 3135 | 0.020 |
Why?
|
| Pharmacogenetics | 1 | 2011 | 683 | 0.020 |
Why?
|
| Administration, Oral | 1 | 2015 | 4030 | 0.020 |
Why?
|
| Fatty Acids, Monounsaturated | 1 | 2008 | 190 | 0.020 |
Why?
|
| Cholesterol, LDL | 2 | 2007 | 2403 | 0.020 |
Why?
|
| Sterol O-Acyltransferase | 1 | 2007 | 28 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2000 | 10101 | 0.020 |
Why?
|
| Electrophoresis, Agar Gel | 1 | 2007 | 205 | 0.020 |
Why?
|
| Cattle | 1 | 1992 | 3819 | 0.020 |
Why?
|
| Coronary Artery Disease | 1 | 2006 | 6568 | 0.020 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2023 | 10399 | 0.020 |
Why?
|
| Phospholipid Transfer Proteins | 1 | 2007 | 90 | 0.020 |
Why?
|
| Forecasting | 1 | 2015 | 2945 | 0.020 |
Why?
|
| Stem Cells | 1 | 1998 | 3537 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinase 8 | 1 | 2004 | 71 | 0.010 |
Why?
|
| Receptors, CCR2 | 1 | 2005 | 216 | 0.010 |
Why?
|
| Cholesterol, Dietary | 1 | 2004 | 224 | 0.010 |
Why?
|
| Mice, Inbred C3H | 1 | 2005 | 915 | 0.010 |
Why?
|
| Molecular Targeted Therapy | 1 | 2015 | 2830 | 0.010 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2015 | 1887 | 0.010 |
Why?
|
| Binding, Competitive | 1 | 2004 | 1142 | 0.010 |
Why?
|
| Intracellular Fluid | 1 | 2002 | 201 | 0.010 |
Why?
|
| Neutrophil Infiltration | 1 | 2005 | 393 | 0.010 |
Why?
|
| Ascitic Fluid | 1 | 2002 | 189 | 0.010 |
Why?
|
| Receptors, Chemokine | 1 | 2005 | 652 | 0.010 |
Why?
|
| Injections, Intraperitoneal | 1 | 2002 | 411 | 0.010 |
Why?
|
| Tryptophan | 1 | 2004 | 482 | 0.010 |
Why?
|
| Alzheimer Disease | 1 | 2003 | 8759 | 0.010 |
Why?
|
| Toll-Like Receptor 9 | 1 | 2002 | 199 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2019 | 15948 | 0.010 |
Why?
|
| Cell Line, Tumor | 2 | 2011 | 17140 | 0.010 |
Why?
|
| Protein Structure, Secondary | 1 | 2004 | 1216 | 0.010 |
Why?
|
| Chemokine CCL2 | 1 | 2003 | 605 | 0.010 |
Why?
|
| Syndrome | 1 | 2007 | 3272 | 0.010 |
Why?
|
| Viral Fusion Proteins | 1 | 2000 | 100 | 0.010 |
Why?
|
| Kinetics | 1 | 2008 | 6329 | 0.010 |
Why?
|
| Combined Modality Therapy | 1 | 2012 | 8542 | 0.010 |
Why?
|
| Toll-Like Receptor 2 | 1 | 2002 | 348 | 0.010 |
Why?
|
| Transcription, Genetic | 2 | 2000 | 7608 | 0.010 |
Why?
|
| Salmonella typhimurium | 1 | 2002 | 348 | 0.010 |
Why?
|
| Chemotaxis | 1 | 2003 | 600 | 0.010 |
Why?
|
| Serine | 1 | 2004 | 831 | 0.010 |
Why?
|
| Gene Transfer, Horizontal | 1 | 2000 | 148 | 0.010 |
Why?
|
| Dactinomycin | 1 | 2000 | 305 | 0.010 |
Why?
|
| Genetic Variation | 1 | 2015 | 6611 | 0.010 |
Why?
|
| Dose-Response Relationship, Immunologic | 1 | 2000 | 361 | 0.010 |
Why?
|
| Homeostasis | 1 | 2011 | 3348 | 0.010 |
Why?
|
| Interleukin-1 | 1 | 2003 | 1252 | 0.010 |
Why?
|
| Amino Acid Substitution | 1 | 2004 | 1743 | 0.010 |
Why?
|
| Protein Isoforms | 1 | 2004 | 1715 | 0.010 |
Why?
|
| Exudates and Transudates | 1 | 1999 | 175 | 0.010 |
Why?
|
| Arachidonate 5-Lipoxygenase | 1 | 1999 | 128 | 0.010 |
Why?
|
| Lipoproteins, VLDL | 1 | 1980 | 201 | 0.010 |
Why?
|
| Recurrence | 1 | 2011 | 8509 | 0.010 |
Why?
|
| Half-Life | 1 | 2000 | 651 | 0.010 |
Why?
|
| Chemokines | 1 | 2003 | 963 | 0.010 |
Why?
|
| Plaque, Amyloid | 1 | 2003 | 769 | 0.010 |
Why?
|
| Calcium | 1 | 1992 | 5792 | 0.010 |
Why?
|
| HL-60 Cells | 1 | 1999 | 364 | 0.010 |
Why?
|
| Triglycerides | 1 | 2006 | 2464 | 0.010 |
Why?
|
| Ear, External | 1 | 1999 | 165 | 0.010 |
Why?
|
| Lipase | 1 | 2000 | 321 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 9 | 1 | 2000 | 534 | 0.010 |
Why?
|
| United States | 2 | 2017 | 73039 | 0.010 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 1980 | 1730 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2000 | 41754 | 0.010 |
Why?
|
| Hindlimb | 1 | 1999 | 516 | 0.010 |
Why?
|
| Streptococcus pneumoniae | 1 | 2002 | 764 | 0.010 |
Why?
|
| Prospective Studies | 2 | 2011 | 54926 | 0.010 |
Why?
|
| Bone Marrow Transplantation | 1 | 2004 | 2709 | 0.010 |
Why?
|
| Cell Adhesion | 1 | 2003 | 3096 | 0.010 |
Why?
|
| Recombination, Genetic | 1 | 2000 | 1525 | 0.010 |
Why?
|
| Anticoagulants | 1 | 2011 | 4852 | 0.010 |
Why?
|
| Respiratory Syncytial Virus Infections | 1 | 2000 | 365 | 0.010 |
Why?
|
| DNA Primers | 1 | 2000 | 2828 | 0.010 |
Why?
|
| Plasmids | 1 | 2000 | 2269 | 0.010 |
Why?
|
| Brain | 1 | 2002 | 27360 | 0.010 |
Why?
|
| Immunophenotyping | 1 | 2000 | 1864 | 0.010 |
Why?
|
| Alternative Splicing | 1 | 2000 | 1105 | 0.010 |
Why?
|
| Rats | 3 | 1992 | 23760 | 0.010 |
Why?
|
| Transcriptional Activation | 1 | 2000 | 1750 | 0.010 |
Why?
|
| Culture Media, Serum-Free | 1 | 1993 | 148 | 0.010 |
Why?
|
| Boston | 1 | 2006 | 9374 | 0.010 |
Why?
|
| Pentetic Acid | 1 | 1993 | 209 | 0.010 |
Why?
|
| Peroxides | 1 | 1993 | 76 | 0.010 |
Why?
|
| Tunica Intima | 1 | 1995 | 459 | 0.010 |
Why?
|
| Free Radicals | 1 | 1993 | 238 | 0.010 |
Why?
|
| Phenotype | 2 | 2007 | 16726 | 0.010 |
Why?
|
| Free Radical Scavengers | 1 | 1993 | 213 | 0.010 |
Why?
|
| Logistic Models | 1 | 2006 | 13290 | 0.010 |
Why?
|
| Inflammation Mediators | 1 | 2000 | 1892 | 0.010 |
Why?
|
| Endothelial Cells | 1 | 2004 | 3589 | 0.010 |
Why?
|
| Type C Phospholipases | 1 | 1992 | 287 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 2000 | 6082 | 0.010 |
Why?
|
| Peptide Fragments | 1 | 2004 | 5151 | 0.010 |
Why?
|
| Receptors, Parathyroid Hormone | 1 | 1992 | 332 | 0.010 |
Why?
|
| Algorithms | 1 | 2011 | 14164 | 0.010 |
Why?
|
| Parathyroid Hormone-Related Protein | 1 | 1992 | 327 | 0.010 |
Why?
|
| Smoking | 1 | 2006 | 9092 | 0.010 |
Why?
|
| Prevalence | 1 | 2006 | 15869 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2006 | 22291 | 0.000 |
Why?
|
| Diabetes Mellitus | 1 | 2006 | 5889 | 0.000 |
Why?
|
| Reproducibility of Results | 1 | 2006 | 20227 | 0.000 |
Why?
|
| Aged, 80 and over | 1 | 2012 | 59629 | 0.000 |
Why?
|
| Oxidation-Reduction | 1 | 1993 | 2227 | 0.000 |
Why?
|
| Osteoblasts | 1 | 1992 | 1145 | 0.000 |
Why?
|
| Interferon-gamma | 1 | 1995 | 3160 | 0.000 |
Why?
|
| Enzyme Activation | 1 | 1992 | 3590 | 0.000 |
Why?
|
| Pituitary Gland | 1 | 1989 | 634 | 0.000 |
Why?
|
| Cross-Sectional Studies | 1 | 2006 | 26379 | 0.000 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2007 | 18065 | 0.000 |
Why?
|
| Obesity | 1 | 2006 | 13090 | 0.000 |
Why?
|
| Antibodies, Monoclonal | 1 | 2000 | 9263 | 0.000 |
Why?
|
| Translocation, Genetic | 1 | 1989 | 1394 | 0.000 |
Why?
|
| Aging | 1 | 1980 | 8744 | 0.000 |
Why?
|
| Risk Factors | 1 | 2006 | 74944 | 0.000 |
Why?
|
| Adolescent | 1 | 2005 | 89169 | 0.000 |
Why?
|